VALANX Biotech

Graz, Austria

VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.

$3.5M raised

Mar 2026

Series Unknown

Biotechnology Health Care Medical Pharmaceutical

Top Investors

SOSVFujifilmXISTA Science Venturesaustria Wirtschaftsservice (aws)tecnet equity

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about VALANX Biotech

How much funding has VALANX Biotech raised?

VALANX Biotech has raised $3.5M in total funding. The most recent round was Series Unknown. The last funding was announced in March 2026.

Who are VALANX Biotech's investors?

VALANX Biotech's investors include SOSV, Fujifilm, XISTA Science Ventures, austria Wirtschaftsservice (aws), tecnet equity.

Where is VALANX Biotech headquartered?

VALANX Biotech is headquartered in Graz, Austria.

What does VALANX Biotech do?

VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.

What stage is VALANX Biotech at?

VALANX Biotech is at the Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 12, 2026.

MLA

"VALANX Biotech — Funding & Investors." VCBacked, March 12, 2026, https://www.vcbacked.co/company/valanx-biotech. Accessed June 3, 2026.

APA

VCBacked. (2026). VALANX Biotech — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/valanx-biotech

Wikipedia (cite web)

{{cite web |title=VALANX Biotech — Funding & Investors |url=https://www.vcbacked.co/company/valanx-biotech |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 12, 2026.

Similar Companies in Biotechnology